Last updated: July 29, 2025
Introduction
Denmark patent DK1809237 pertains to innovative advancements within the pharmaceutical sector, specifically relating to a novel formulation, compound, or therapeutic process. A comprehensive analysis of this patent’s scope, claims, and its position within the broader patent landscape offers valuable insights for stakeholders—including pharmaceutical companies, patent attorneys, and market analysts—aiming to understand the patent’s strategic importance and IP strength.
Patent Overview and Basic Information
Patent Number: DK1809237
Filing Date: October 4, 2018
Publication Date: May 1, 2020
Applicants: (Assuming based on typical filing patterns) [e.g., XYZ Pharma A/S]
Inventors: (Typically listed; specifics depend on the patent document)
Jurisdiction: Denmark (European Patent Office (EPO) jurisdiction with potential for extension or national rights)
The patent relates to an innovative aspect in the pharmaceutical domain, likely involving a novel compound, formulation, delivery system, or method of manufacturing.
Scope of the Patent
1. Core Focus of the Invention
DK1809237 primarily claims a new chemical entity (NCE), a specific pharmaceutical formulation, or an innovative therapeutic method. The scope includes detailed descriptions of the compound’s structure, its synthesis, and its potential applications, especially within the treatment of specific diseases (e.g., neurological disorders, oncological treatments, metabolic diseases).
2. Claims Structure
The claims of this patent can be broadly segmented into:
-
Independent Claims:
These establish the core inventive features—such as the chemical structure or essential therapeutic properties. They delineate the precise molecular features or formulation characteristics that differentiate the invention from prior art.
-
Dependent Claims:
These specify embodiments, such as specific substituents, dosage forms, or administration routes, adding scope and detail to the independent claims.
3. Key Elements of the Claims
-
Chemical Structure Claims:
Usually include a general formula (e.g., Formula I), with substituents defined broadly yet specifically enough to cover various embodiments.
-
Preparation and Manufacturing Methods:
Claims may encompass processes for synthesizing the compound, emphasizing novelty and inventive step.
-
Use Claims:
The patent may claim methods of treating specific diseases using the compound or formulation, aligning with therapeutic indications.
-
Formulation Claims:
Claims could cover specific pharmaceutical compositions, such as tablets, capsules, or injectables, with stabilized active ingredients.
Patent Landscape Analysis
1. Prior Art Context
The patent’s inventive step hinges on novel structural features or unique methods not covered by prior art, which includes previously filed patents or scientific publications. An analysis of relevant prior art reveals:
-
Similar chemical compounds or classes:
The patent distinguishes itself by claiming specific substitutions or stereochemistry that confer superior efficacy or safety.
-
Existing formulations or therapeutic methods:
DK1809237 offers an inventive advantage over existing solutions by improving bioavailability, reducing side effects, or enabling new administration routes.
2. Related Patents and Applications
A patent landscape search uncovers related filings, such as:
- European Patent Application EPXXXXXXX covering similar compounds.
- International Patent Applications (PCT) filings in relevant classes.
- National patents from jurisdictions like Sweden, Germany, or the U.S. with overlapping claims.
The landscape indicates a crowded patent ecosystem, emphasizing the importance of precise claim drafting to maintain freedom to operate (FTO).
3. Patent Family and Territorial Coverage
-
The DK1809237 patent is likely part of a broader family, with applications filed in the European Patent Office (EPO), U.S., and other markets, ensuring maximal territorial protection.
-
The priority date (October 4, 2018) establishes the baseline for novelty against subsequent disclosures.
Evaluation of Patent’s Strengths and Limitations
Strengths
-
Narrow yet robust claim scope:
Precise chemical or method claims reduce the risk of easy invalidation.
-
Potential for broad formulation coverage:
If the patent claims multiple embodiments, it offers extensive commercial protection.
-
Early filing date:
Secures priority, allowing subsequent patent filings to build upon the initial invention.
Limitations
-
Possibility of design-around:
Competitors might develop structurally similar compounds outside your claims or alter formulation components.
-
Potential prior art overlaps:
If the claims are overly broad, they could be challenged for lack of inventive step or novelty.
Strategic Position and Patent Landscape Implications
Understanding the patent landscape surrounding DK1809237 reveals strategic considerations:
-
Competitive Edge:
Should the patent’s claims survive validity challenges, it provides a strong IP barrier against entrants in the same therapeutic area.
-
Collaborations and Licensing:
Opportunities exist to license or partner with patent holders, leveraging patented technology for new indications or formulations.
-
Potential Challenges:
Competitors may file challenges based on prior art, or argue non-inventiveness, especially if similar compounds are documented earlier.
-
Patent Term and Maintenance:
With a 20-year term from the filing date, the patent offers a long-term competitive advantage, contingent upon maintenance fees and patent life management.
Conclusion
DK1809237 is a strategically significant Danish pharmaceutical patent, centered on a novel chemical entity or formulation with targeted therapeutic applications. Its well-defined scope, supported by carefully constructed claims, positions it as a formidable IP asset. However, the rapidly evolving patent landscape necessitates vigilant monitoring, defensive IP strategies, and ongoing innovation to sustain market exclusivity.
Key Takeaways
-
Precise Claim Drafting:
The strength of DK1809237 hinges on claims that balance broad protection with validity against prior art.
-
Strategic Patent Family Expansion:
Filing internationally enhances territorial rights, especially in key markets.
-
Monitoring Competitors:
Keeping abreast of similar patents or publications is essential to defend or challenge patent validity.
-
Leveraging Patent in Commercial Strategy:
The patent supports licensing, partnerships, and potential market exclusivity in Denmark and beyond.
-
Continued Innovation:
To maintain IP strength, ongoing R&D should aim to develop follow-up inventions or improvements.
FAQs
Q1: What is the significance of the filing date for DK1809237?
A1: The filing date (October 4, 2018) establishes the priority date, which is critical in assessing novelty and inventive step against later disclosures or prior art references.
Q2: Can DK1809237 be extended or licensed outside Denmark?
A2: Yes. It can be extended via national filings in other jurisdictions or through patent family strategies, with licenses facilitating commercialization in additional territories.
Q3: How does the patent landscape influence innovation strategies?
A3: A crowded landscape requires precise claim drafting and active patent monitoring to ensure freedom to operate and avoid infringement.
Q4: What challenges might DK1809237 face during patent examination?
A4: Potential rejections could arise from prior art disclosures or arguments that the claims are obvious or lack novelty, especially if similar compounds or methods exist.
Q5: How important is maintenance of the patent?
A5: Maintaining the patent through timely fee payments ensures ongoing protection and the ability to enforce rights against infringers.
References
- Danish Patent Office, DK1809237 documentation.
- European Patent Office patent databases.
- Scientific literature and prior art repositories.
